Biliary Atresia: When Is Transplant Needed After Kasai?
At a Glance
After a Kasai procedure, liver transplant timing is individualized rather than set by a calendar. Doctors monitor bilirubin, liver function, growth, infections, bleeding risks, and quality of life; early evaluation does not mean a child will be listed immediately.
In this answer
3 sections
Living with the uncertainty of what comes after a Kasai procedure can be incredibly stressful for parents. While the Kasai portoenterostomy is the first-line treatment to restore bile flow, as this guide notes, 50% to 80% of children with isolated biliary atresia will eventually require a liver transplant [1].
It is important to understand that the timing of a liver transplant is not based on a fixed calendar. Instead, it is determined by continuously monitoring your child’s liver function, physical growth, and quality of life [1][2]. Because predicting the exact timeline is impossible, doctors often recommend an early transplant evaluation. An evaluation is simply a precautionary step to gather a specialist team and make a personalized care plan—it does not mean your child will be listed for a transplant immediately [3].
An Important 3-Month Milestone: Bilirubin Clearance
In the first three months following the Kasai procedure, your care team will closely monitor your child’s total bilirubin levels. A common prognostic milestone is for total bilirubin to fall below 2.0 mg/dL [4][5].
Reaching this milestone is a strong indicator that bile is draining, which significantly improves the chances of your child surviving with their native (original) liver for years [4]. However, it is not a rigid pass/fail test. If bilirubin remains at or above 2.0 mg/dL after three months, it does not automatically mean an immediate transplant is required. Rather, it is a signal to promptly refer your child to a transplant center for a comprehensive evaluation [4][3].
Triggers That Prompt Transplant Evaluation
Even if bilirubin levels clear initially, the liver can still experience ongoing inflammation and scarring, known as fibrosis [6]. Your child’s medical team will look for specific clinical “triggers” that indicate the liver is struggling [1]:
- Recurrent Cholangitis: Cholangitis is an infection of the bile ducts. While some episodes can be treated with antibiotics, frequent or difficult-to-control infections can cause further liver damage [7][8]. Any fever or suspected cholangitis after a Kasai procedure requires prompt, same-day medical contact, as fever may be the only obvious sign of a serious infection.
- Failing Liver Function (Decompensation): Doctors track if the liver is losing its ability to function. Signs include worsening blood clotting times (such as a high INR despite vitamin K), falling albumin levels, or sudden confusion and severe lethargy [9].
- Persistent Growth Faltering: A lack of bile in the intestines means the body struggles to absorb fats and fat-soluble vitamins (A, D, E, and K) [10]. If your child experiences poor growth that does not improve despite aggressive nutritional and dietitian support, a transplant evaluation may be triggered [1][3].
- Severe Portal Hypertension: As the liver scars, blood flow through it becomes restricted, causing high blood pressure in the main vein leading to the liver, known as portal hypertension [9]. This can cause fluid buildup in the belly (ascites), enlarged bleeding-prone veins in the esophagus or stomach (varices), and a drop in blood platelets [9][11]. Vomiting blood, having black or bloody stools, or experiencing sudden, severe abdominal swelling are medical emergencies that require immediate care [12].
- Quality of Life and Complications: Severe, unrelenting itching, extreme fatigue, or breathing difficulties caused by lung complications (such as hepatopulmonary syndrome) are also critical factors that can make a transplant necessary [13][1].
Scoring Systems and the Path to Listing
Deciding exactly when to place a child on the transplant waiting list requires balancing the risks of the surgery against the risks of waiting. To support their clinical judgment, doctors use predictive models and scoring systems to predict the safest, most optimal time to list a child for transplant [1][9].
The most common system is the PELD score (Pediatric End-Stage Liver Disease), which calculates a risk number based on your child’s routine lab results and physical growth, and is used primarily for organ allocation [14]. You might also hear your team refer to other models or registries (such as BARC or BARD, which relate to liver scarring scales and long-term data collection) that help track a child’s history of complications like ascites or cholangitis [15][16][9].
These scores do not replace your specialist team’s judgment, nor do they perfectly predict a single “optimal” date for a transplant. The typical pathway is: Kasai follow-up → early transplant evaluation (precautionary) → potential listing (when risks of waiting outweigh risks of surgery) → transplant [1][3].
Common questions in this guide
Does every child with biliary atresia need a transplant after the Kasai procedure?
When do doctors start considering a transplant after Kasai?
What bilirubin level is reassuring about three months after Kasai?
What problems can trigger transplant evaluation after Kasai?
What does the PELD score tell doctors about transplant listing?
What should I do if my child has a fever or signs of bleeding after Kasai?
Related questions
Show more
Get notified when new evidence is published on Isolated biliary atresia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Biliary atresia: Indications and timing of liver transplantation and optimization of pretransplant care.
Sundaram SS, Mack CL, Feldman AG, Sokol RJ
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2017; (23(1)):96-109 doi:10.1002/lt.24640.
PMID: 27650268 - 2
Implementing Continuous Nursing Care After Kasai Procedure in Infants with Biliary Atresia.
Cheng Y, Zuo W, Gao W, et al.
Journal of visualized experiments : JoVE 2026; doi:10.3791/69973.
PMID: 41770696 - 3
Advances in pediatric liver transplantation from the pediatric surgeon's perspective.
Tanaka H
Pediatric surgery international 2023; (39(1)):253 doi:10.1007/s00383-023-05533-8.
PMID: 37624479 - 4
Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia.
Shneider BL, Magee JC, Karpen SJ, et al.
The Journal of pediatrics 2016; (170()):211-7.e1-2.
PMID: 26725209 - 5
Predictors of Need for Liver Transplantation in Children Undergoing Hepatoportoenterostomy for Biliary Atresia.
Ramos-Gonzalez G, Elisofon S, Dee EC, et al.
Journal of pediatric surgery 2019; (54(6)):1127-1131 doi:10.1016/j.jpedsurg.2019.02.051.
PMID: 30879751 - 6
Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy.
Harpavat S, Hawthorne K, Setchell KDR, et al.
Hepatology (Baltimore, Md.) 2023; (77(3)):862-873 doi:10.1002/hep.32800.
PMID: 36131538 - 7
Annual cholangitis more than twice predicts liver transplant in biliary atresia patients who achieve jaundice-free after Kasai portoenterostomy.
Liu SH, Chen CC, Chao HC, et al.
Journal of the Formosan Medical Association = Taiwan yi zhi 2026; (125(3)):275-282 doi:10.1016/j.jfma.2025.01.006.
PMID: 39818465 - 8
Nationwide outcomes of biliary atresia after Kasai portoenterostomy in Taiwan: the impact of postoperative cholangitis and corticosteroid use.
Yang HH, Huang WT, Wang JH, et al.
Pediatric surgery international 2026; (42(1)).
PMID: 42900357 - 9
Modeling Outcomes in Children With Biliary Atresia With Native Liver After 2 Years of Age.
Venkat V, Ng VL, Magee JC, et al.
Hepatology communications 2020; (4(12)):1824-1834 doi:10.1002/hep4.1602.
PMID: 33305153 - 10
Long-term outcomes of biliary atresia patients surviving with their native livers.
Hukkinen M, Ruuska S, Pihlajoki M, et al.
Best practice & research. Clinical gastroenterology 2022; (56-57()):101764 doi:10.1016/j.bpg.2021.101764.
PMID: 35331404 - 11
Operational Definitions for Chronic Liver Disease Manifestations and Recurring Clinical Events in Biliary Atresia.
Shiau H, Schraw JM, Cavallo L, et al.
Journal of pediatric gastroenterology and nutrition 2021; (72(4)):584-591 doi:10.1097/MPG.0000000000002992.
PMID: 33306582 - 12
Predicting variceal bleeding in patients with biliary atresia.
Sohn H, Park S, Kang Y, et al.
Scandinavian journal of gastroenterology 2019; (54(11)):1385-1390 doi:10.1080/00365521.2019.1683225.
PMID: 31646915 - 13
Late complications of biliary atresia: hepatopulmonary syndrome and portopulmonary hypertension.
Karrer FM, Wallace BJ, Estrada AE
Pediatric surgery international 2017; (33(12)):1335-1340 doi:10.1007/s00383-017-4176-2.
PMID: 28983709 - 14
An Unexpected Hepatic Hydrothorax After a Successful Kasai Portoenterostomy: A Case Report.
Ranucci G, Di Dato F, Liccardo D, et al.
Frontiers in pediatrics 2021; (9()):766187 doi:10.3389/fped.2021.766187.
PMID: 34790637 - 15
YAP Activation and Implications in Patients and a Mouse Model of Biliary Atresia.
Zheng C, Luo J, Yang Y, et al.
Frontiers in pediatrics 2020; (8()):618226 doi:10.3389/fped.2020.618226.
PMID: 33553074 - 16
Centralization of Biliary Atresia: Has Germany Learned Its Lessons?
Madadi-Sanjani O, Fortmann D, Rolle U, et al.
European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie 2022; (32(3)):233-239 doi:10.1055/s-0041-1723994.
PMID: 33663007
This page explains transplant evaluation timing after a Kasai procedure for educational purposes only and does not replace medical advice from your child's liver or transplant team. Seek urgent care for emergency signs such as vomiting blood, black or bloody stools, or severe abdominal swelling.